These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2025960)

  • 1. Induction of cutaneous graft-versus-host disease by local injection of unprimed T cells.
    Kawai K; Matsumoto Y; Watanabe H; Ito M; Fujiwara M
    Clin Exp Immunol; 1991 May; 84(2):359-66. PubMed ID: 2025960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Barrett TA; Bluestone JA; Vallera DA
    Blood; 1996 Jan; 87(2):827-37. PubMed ID: 8555509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.
    Sprent J; Schaefer M; Korngold R
    J Immunol; 1990 Apr; 144(8):2946-54. PubMed ID: 1969878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function.
    Via CS; Shanley JD; Shearer GM
    J Immunol; 1990 Nov; 145(10):3283-9. PubMed ID: 2172381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients.
    Blazar BR; Taylor PA; Vallera DA
    Transplantation; 1997 Aug; 64(4):571-6. PubMed ID: 9293867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.
    Baker MB; Altman NH; Podack ER; Levy RB
    J Exp Med; 1996 Jun; 183(6):2645-56. PubMed ID: 8676085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.
    Welniak LA; Blazar BR; Anver MR; Wiltrout RH; Murphy WJ
    Biol Blood Marrow Transplant; 2000; 6(6):604-12. PubMed ID: 11128810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL; Bryde SE; Lipsky PE
    J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
    Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
    Rolink AG; Pals ST; Gleichmann E
    J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier.
    Serody JS; Cook DN; Kirby SL; Reap E; Shea TC; Frelinger JA
    Blood; 1999 Jan; 93(1):43-50. PubMed ID: 9864144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
    Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
    J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
    El-Hayek JM; Rogers TE; Brown GR
    J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cutaneous graft-versus-host disease by allo- or self-Ia-reactive helper T cells in mice.
    Shiohara T; Narimatsu H; Nagashima M
    Transplantation; 1987 May; 43(5):692-8. PubMed ID: 2437672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.